The trademark application was filed by Takeda Pharmaceuticals International AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on April 15, 2021, and it was registered by office on July 22, 2021 without any oppositions.
The application was filed in German (English was selected as the second language).